Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Christopher S. Badorrek"'
Autor:
Julie A. Ake, Kristopher Paolino, Jack N. Hutter, Susan Biggs Cicatelli, Leigh Anne Eller, Michael A. Eller, Margaret C. Costanzo, Dominic Paquin-Proulx, Merlin L. Robb, Chi L. Tran, Lalaine Anova, Linda L. Jagodzinski, Lucy A. Ward, Nicole Kilgore, Janice Rusnak, Callie Bounds, Christopher S. Badorrek, Jay W. Hooper, Steven A. Kwilas, Ine Ilsbroux, Dickson Nkafu Anumendem, Auguste Gaddah, Georgi Shukarev, Viki Bockstal, Kerstin Luhn, Macaya Douoguih, Cynthia Robinson
Publikováno v:
Vaccines, Vol 12, Iss 5, p 497 (2024)
The safety and immunogenicity of the two-dose Ebola vaccine regimen MVA-BN-Filo, Ad26.ZEBOV, 14 days apart, was evaluated in people without HIV (PWOH) and living with HIV (PLWH). In this observer-blind, placebo-controlled, phase 2 trial, healthy adul
Externí odkaz:
https://doaj.org/article/d508ae26d5664c20827179054ade0b7e
Autor:
Thomas L. Rudge, Nicholas J. Machesky, Karen A. Sankovich, Erin E. Lemmon, Christopher S. Badorrek, Rachel Overman, Nancy A. Niemuth, Michael S. Anderson
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1211 (2022)
Since the discovery of the Marburg virus (MARV) in 1967 and Ebola virus (EBOV) in 1976, there have been over 40 reported outbreaks of filovirus disease with case fatality rates greater than 50%. This underscores the need for efficacious vaccines agai
Externí odkaz:
https://doaj.org/article/d4a6d683966d49e69f450f38764f05cb
Autor:
Janice M. Rusnak, Pamela J. Glass, Scott C. Weaver, Carol L. Sabourin, Andrew M. Glenn, William Klimstra, Christopher S. Badorrek, Farooq Nasar, Lucy A. Ward
Publikováno v:
Viruses, Vol 11, Iss 9, p 807 (2019)
Licensure of a vaccine to protect against aerosolized Venezuelan equine encephalitis virus (VEEV) requires use of the U.S. Food and Drug Administration (FDA) Animal Rule to assess vaccine efficacy as human studies are not feasible or ethical. An appr
Externí odkaz:
https://doaj.org/article/135a5c3ffec4495cb89500564d751b9d
Autor:
Michael S Anderson, Nancy A Niemuth, Carol L Sabourin, Christopher S Badorrek, Callie E Bounds, Thomas L Rudge
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0238196 (2020)
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the devastating 2014-2016 outbreak of Ebola virus (EBOV) disease (EVD) in Guinea, Sierra Leone, and Liberia that resulted in over 28,000 cases and over 11,300
Externí odkaz:
https://doaj.org/article/ad669183e1d0412bb45a8896fee14765
Autor:
Nancy A Niemuth, Thomas L Rudge, Karen A Sankovich, Michael S Anderson, Nicholas D Skomrock, Christopher S Badorrek, Carol L Sabourin
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241016 (2020)
An anti-Zaire Ebola virus (EBOV) glycoprotein (GP) immunoglobulin G (IgG) enzyme linked immunosorbent assay (ELISA) was developed to quantify the serum levels of anti-EBOV IgG in human and non-human primate (NHP) serum following vaccination and/or ex
Externí odkaz:
https://doaj.org/article/409e0837db0549c7b44c423e13bf373f
Autor:
Thomas L Rudge, Karen A Sankovich, Nancy A Niemuth, Michael S Anderson, Christopher S Badorrek, Nick D Skomrock, Chris M Cirimotich, Carol L Sabourin
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215457 (2019)
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the recent and devastating 2014-2016 outbreak of Ebola virus (EBOV) disease in Guinea, Sierra Leone, and Liberia that resulted in more than 10,000 casualties.
Externí odkaz:
https://doaj.org/article/f4d526e81a16443ca33df9ab020835db
Autor:
Julie A. Ake, Kristopher Paolino, Jack N. Hutter, Susan Biggs Cicatelli, Leigh Anne Eller, Michael A. Eller, Margaret C. Costanzo, Dominic Paquin-Proulx, Merlin L. Robb, Chi L. Tran, Lalaine Anova, Linda L. Jagodzinski, Lucy A. Ward, Nicole Kilgore, Janice Rusnak, Callie Bounds, Christopher S. Badorrek, Jay W. Hooper, Steve Kwilas, Ine Ilsbroux, Dickson Nkafu Anumendem, Auguste Gaddah, Georgi Shukarev, Viki Bockstal, Kerstin Luhn, Macaya Douoguih, Cynthia Robinson
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29b474386537b6fd7a678ee9537b0891
https://doi.org/10.2139/ssrn.3978575
https://doi.org/10.2139/ssrn.3978575
Autor:
Carol L. K. Sabourin, Callie E. Bounds, Thomas L. Rudge, Christopher S. Badorrek, Nancy A. Niemuth, Michael S. Anderson
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0238196 (2020)
PLoS ONE
PLoS ONE
The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the devastating 2014–2016 outbreak of Ebola virus (EBOV) disease (EVD) in Guinea, Sierra Leone, and Liberia that resulted in over 28,000 cases and over 11,3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dda856dcb4700d8d6f2801aabed551c
https://doaj.org/article/ad669183e1d0412bb45a8896fee14765
https://doaj.org/article/ad669183e1d0412bb45a8896fee14765
Autor:
Christopher S. Badorrek, Carol L. K. Sabourin, Michael S. Anderson, Karen A. Sankovich, Nicholas D. Skomrock, Thomas L. Rudge, Nancy A. Niemuth
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241016 (2020)
PLoS ONE
PLoS ONE
An anti-Zaire Ebola virus (EBOV) glycoprotein (GP) immunoglobulin G (IgG) enzyme linked immunosorbent assay (ELISA) was developed to quantify the serum levels of anti-EBOV IgG in human and non-human primate (NHP) serum following vaccination and/or ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b243c70ec9cddf225e0093f72d7073fc
https://doaj.org/article/409e0837db0549c7b44c423e13bf373f
https://doaj.org/article/409e0837db0549c7b44c423e13bf373f
Autor:
W. Jay Ramsey, Donna MacKinnon-Cameron, Catherine Brown, Steven A Kwilas, Scott A. Halperin, D. Gray Heppner, Tracy Kemp, Teresa Nowak, Li Li, Thomas P. Monath, May Elsherif, Jay W. Hooper, Shelly A. McNeil, Carol Sabourin, Christopher S. Badorrek, Trina Racine, Peter Silvera, Thomas L. Rudge, Nicole Kilgore, Judie Alimonti, Joanne M. Langley
Publikováno v:
Canadian Medical Association Journal. 189:E819-E827
BACKGROUND: The 2013–2016 Ebola virus outbreak in West Africa was the most widespread in history. In response, alive attenuated recombinant vesicular stomatitis virus (rVSV) vaccine expressing Zaire Ebolavirus glycoprotein (rVSVΔG-ZEBOV-GP) was ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6497fb1613a605e895f33fc5392b831e
https://doi.org/10.1503/cmaj.170074
https://doi.org/10.1503/cmaj.170074